Cardiology

Ivabradine may not benefit certain heart failure patients

Researchers have completed a randomized clinical trial in patients with heart failure with preserved ejection fraction (HFpEF), which currently has no effective treatment for reducing morbidity and mortality.

Neuroscience

Musical training creates new brain connections in children

Taking music lessons increases brain fiber connections in children and may be useful in treating autism and Attention Deficit Hyperactivity Disorder (ADHD), according to a study being presented next week at the annual meeting ...

Cardiology

Spironolactone benefits exercise tolerance in HFpEF

(HealthDay)—For patients with heart failure with preserved ejection fraction (HFpEF) with an exercise-induced increase in the ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e'), ...

Cardiology

Three-drug tx ups survival in light-chain amyloidosis

(HealthDay)—For patients with heart failure due to light-chain amyloidosis (AL), three-drug therapy with bortezomib, dexamethasone, and an alkylating agent (BDex+AA) is associated with improved survival, according to a ...

Cardiology

ESC Guidelines on acute and chronic heart failure launched today

European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure are published today in European Heart Journal and the European Journal of Heart Failure, and presented at ...

Cardiology

Study identifies aortic valve gradient as key to TAVR outcomes

Patients with a combination of left ventricular dysfunction and low aortic valve gradient, or reduced force of blood flow through the aortic valve, have higher mortality rates and a greater risk of recurrent heart failure ...

page 16 from 25